Skip to main content
. 2021 Oct 20;7(11):888. doi: 10.3390/jof7110888

Table 2.

Risk factors for severe disease.

Mild/Moderate Disease (n = 164) Severe Disease (n = 46) Univariate
Odds Ratio (95% CI)
p-Value Multivariate
Odds Ratio (95% CI)
p-Value
Age in years
Mean (SD)
51.2 (18.13) 51.3 (18.81) 1.00 (0.98–1.02) 0.960
Male Sex 70.1 (115/164) 73.9 (34/46) 1.21 (0.58–2.53) 0.617
Race
White 91.3 (136/149) 86.1 (37/43) Reference
Black 3.4 (5/149) 7.0 (3/43) 2.21 (0.50–9.66) 0.294
Asian 4.7 (7/149) 2.3 (1/43) 0.53 (0.06–4.40) 0.553
American Indian 0.7 (1/149) 4.7 (2/43) 7.35 (0.65–83.32) 0.107
Hispanic 3.7 (5/135) 0 -
Asthma/COPD 9.8 (16/164) 6.5 (3/46) 0.65 (0.18–2.32) 0.502
Diabetes mellitus
All 23.2 (38/164) 21.7 (10/46) 0.92 (0.42–2.03) 0.838
Insulin-Dependent 7.9 (13/164) 13.0 (6/46) 1.74 (0.62–4.87) 0.290
Renal Failure 5.4 (8/149) 15.6 (7/45) 3.25 (1.11–9.52) 0.032 2.43 (0.79–7.46) 0.119
Obesity 31.5 (47/149) 41.9 (18/43) 1.56 (0.78–3.14) 0.210
Extrapulmonary Disease 26.2 (43/164) 19.6 (9/46) 0.68 (0.31–1.53) 0.357
Corticosteroid Treatment 7.9 (13/164) 4.4 (2/46) 0.53 (0.11–2.43) 0.412
Pharmacologic Immunosuppression 19.5 (32/164) 15.2 (7/46) 0.74 (0.30–1.81) 0.509
Solid Organ Transplant 6.7 (11/164) 10.9 (5/46) 1.70 (0.56–5.16) 0.352
Neutrophilia 1 43.1 (59/137) 72.7 (32/44) 3.52 (1.67–7.42) 0.001 3.35 (1.53–7.35) 0.002
Lymphopenia 2 27.7 (38/137) 59.1 (26/44) 3.76 (1.85–7.64) <0.001 3.34 (1.59–7.03) 0.001

Data are presented as percentages (absolute numbers shown in parentheses), unless otherwise indicated. CI, confidence interval; COPD, chronic obstructive pulmonary disease. 1 Neutrophil count ≥ 7.5 × 103cells/microL. 2 Lymphocyte count < 1.0 × 103 cells/microL.